Loading market dashboard
Rigel Pharmaceuticals, Inc.
RIGLHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Rigel Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $387.35M | $356.35M - $415.66M | -$4.87M | $3.737 | 2 |
| Dec 2029 | $358.35M | $329.67M - $384.54M | -$4.50M | $3.177 | 2 |
| Dec 2028 | $370.46M | $370.46M - $370.46M | -$4.65M | $4.764 | 5 |
| Dec 2027 | $329.58M | $310.89M - $348.28M | -$4.14M | $4.376 | 4 |
| Dec 2026 | $269.78M | $268.04M - $271.51M | -$3.39M | $3.149 | 4 |
| Dec 2025 | $293.19M | $293.18M - $293.20M | -$3.68M | $6.638 | 3 |
| Dec 2024 | $171.80M | $158.05M - $184.35M | -$2.16M | $0.389 | 2 |
| Dec 2023 | $130.20M | $119.78M - $139.72M | -$1.64M | -$0.814 | 1 |
| Dec 2022 | $97.78M | $89.27M - $110.23M | -$74.78M | -$4.531 | 1 |
| Dec 2021 | $150.63M | $137.52M - $169.79M | -$23.04M | -$1.023 | 1 |
| Dec 2020 | $108.56M | $99.11M - $122.37M | -$16.60M | -$1.724 | 2 |
| Dec 2019 | $59.57M | $54.39M - $67.15M | -$71.42M | -$3.778 | 1 |